[SRNE] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
08-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -31.60%
YoY- -76.78%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 142 134 122 135 217 110 128 7.17%
PBT -4,737 -2,522 -3,236 -1,241 -943 -906 -3,236 28.95%
Tax 2 2 -3,090 4 4 3 -2,474 -
NP -4,737 -2,522 -1,755 -1,241 -943 -906 -762 238.46%
Tax Rate - - - - - - - -
Total Cost 4,878 2,656 1,877 1,376 1,160 1,016 890 211.18%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -3,345.11 -1,881.46 -1,438.58 -922.81 -434.35 -822.64 -595.84 216.21%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -0.35 -0.20 -0.14 -0.10 -0.08 -0.09 -0.07 192.68%
EPS Diluted -0.35 -0.20 -0.14 -0.10 -0.08 -0.09 -0.07 192.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.